These data are analyzes of the results of a multicenter.

We are pleased this study provides the assurance that a viable treatment a viable treatment option for older adults. .. These data are analyzes of the results of a multicenter, randomized, double-blind, placebo-controlled, parallel – groups, three-week study of 150 healthy older adults . Results after three weeks out that Enablex had no significant effect on memory function and was comparable to placebo as measured by delayed retrieval accuracy on the name-Face Association test . This was the primary endpoint for this study.

– Novartis Pharmaceuticals Corporation and Procter & Gamble Pharmaceuticals , a division of The Procter & Gamble Company, at the co-promotion and further development of Enablex? extended-release tablets for the treatment of overactive bladder in the United States. The foregoing release contains forward-looking statements that can be identified by terminology such as development or similar expressions or by express or implied discussions regarding potential new indications or labeling for Enablex or potential future sales of Enablex. Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results with Enablex be expressed materially from any future results, performance or achievements expressed expressed or implied by such statements vary.‘Right now, we will get a a positive response ‘for develop a concept and tongue, he said. ‘But, of course might changed that, when these ideas to be get out on the table discussion. ‘.